TABLE I.
Step | Preferred controller medication | Alternative controller medication |
---|---|---|
1 | None | — |
2 | Low-dose ICS | LTRA, theophylline, or cromolyn |
3 | Medium-dose ICS or low-dose ICS plus LABA | Low-dose ICS plus LTRA or theophylline |
4 | Medium-dose ICS plus LABA | Medium-dose ICS plus either LTRA or theophylline |
5 | High-dose ICS plus LABA | Medium-dose ICS plus LABA plus tiotropium; consider adding omalizumab for patients with allergy or adding other asthma biologics (anti–IL-5, anti–IL-5Rα, anti–IL-4Rα) for appropriate candidates |
6 | High-dose ICS plus LABA plus oral prednisone | Consider adding omalizumab for patients with allergy or adding other asthma biologics (anti–IL-5, anti–IL-5Rα, anti–IL-4Rα) for appropriate candidates |
ICS, Inhaled corticosteroid; LABA, long-acting β-agonist; LTRA, leukotriene receptor antagonist.
There are no randomized clinical trials of asthma biologics that intentionally included pregnant women.
Data modified from Schatz and Dombrowski.13